An increase in apelin (i.e., raised to levels between 1.63–3.52 ng/mL) [48,49] may lead to improved vasodilation, heart contractility, GLUT 4 activity and energy metabolism in overweight, hyperlipidemia and diabetes patients [50,51]. This evidence concerns the gene APLN and diabetes mellitus.